Ladenburg Thalmann Financial Services’s Collegium Pharmaceutical COLL Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$0	Sell	24 -2	-8%	-$33	﹤0.01%	5343
2019 Q3	$0	Sell	26 -601	-96%	-$6.86K	﹤0.01%	5292
2019 Q2	$8K	Sell	627 -2	-0.3%	-$27	﹤0.01%	4516
2019 Q1	$10K	Buy	629 +398	+172%	+$6.37K	﹤0.01%	4358
2018 Q4	$4K	Sell	231 -244	-51%	-$4.17K	﹤0.01%	4667
2018 Q3	$7K	Buy	+475	New	+$8.42K	﹤0.01%	4438

Other funds holding COLL

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Ladenburg Thalmann Financial Services's COLL Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its Collegium Pharmaceutical (COLL) stake by 7.7% in Q4 2019, selling an estimated $33 and leaving 24 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5343.

Ladenburg Thalmann Financial Services first reported a position in COLL in Q3 2018 and has held it in 6 quarters since. The position peaked at $10K in Q1 2019. 138 funds tracked by Wall St. Rank hold COLL as of Q4 2019.

Ladenburg Thalmann Financial Services held 24 shares of Collegium Pharmaceutical worth $0 as of Q4 2019.
Ladenburg Thalmann Financial Services sold 2 Collegium Pharmaceutical shares in Q4 2019, an estimated $33.
Collegium Pharmaceutical made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5343 holding.
Ladenburg Thalmann Financial Services first reported a position in Collegium Pharmaceutical in Q3 2018 and has held it in 6 quarters since.
Ladenburg Thalmann Financial Services's Collegium Pharmaceutical position peaked at $10K in Q1 2019.
138 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.